- Home
- LNTH vs WCC Comparison
LNTH vs WCC Comparison
Compare LNTH & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- WCC
- Stock Information
- Founded
- LNTH 1956
- WCC 1922
- Country
- LNTH United States
- WCC United States
- Employees
- LNTH N/A
- WCC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WCC Telecommunications Equipment
- Sector
- LNTH Health Care
- WCC Consumer Discretionary
- Exchange
- LNTH Nasdaq
- WCC Nasdaq
- Market Cap
- LNTH 7.5B
- WCC 8.1B
- IPO Year
- LNTH 2015
- WCC 1999
- Fundamental
- Price
- LNTH $75.56
- WCC $167.86
- Analyst Decision
- LNTH Strong Buy
- WCC Buy
- Analyst Count
- LNTH 5
- WCC 8
- Target Price
- LNTH $133.80
- WCC $212.00
- AVG Volume (30 Days)
- LNTH 1.5M
- WCC 635.2K
- Earning Date
- LNTH 05-07-2025
- WCC 05-01-2025
- Dividend Yield
- LNTH N/A
- WCC 1.08%
- EPS Growth
- LNTH N/A
- WCC 10.34
- EPS
- LNTH 3.53
- WCC 13.26
- Revenue
- LNTH $1,536,699,000.00
- WCC $21,812,500,000.00
- Revenue This Year
- LNTH $4.63
- WCC $4.13
- Revenue Next Year
- LNTH $9.35
- WCC $4.27
- P/E Ratio
- LNTH $21.40
- WCC $12.66
- Revenue Growth
- LNTH 12.53
- WCC N/A
- 52 Week Low
- LNTH $73.11
- WCC $125.21
- 52 Week High
- LNTH $126.89
- WCC $216.17
- Technical
- Relative Strength Index (RSI)
- LNTH 32.65
- WCC 52.67
- Support Level
- LNTH $73.75
- WCC $161.70
- Resistance Level
- LNTH $76.34
- WCC $175.36
- Average True Range (ATR)
- LNTH 2.50
- WCC 4.00
- MACD
- LNTH -0.09
- WCC -0.29
- Stochastic Oscillator
- LNTH 23.36
- WCC 41.51
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About WCC WESCO International Inc.
Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.